Jack Roth, MD, Oral History Interview, The First 50 Years of Surgery at MD Anderson (1945 – 1995), March 14, 2019
Files
Download Navigation Materials and Full Transcript (193 KB)
Loading...
Media is loading
Description
Major Topics Covered:
- Research: gene therapy; immunotherapy;The Division of Surgery: shifts in philosophy; resources and support of; evolution of research within;
- The Division system: advantages of system; impact on growth of surgery
- Department of Thoracic and Cardiovascular Surgery: Research within; shift to a surgical oncology perspective; training programs
Interview Chapters
- Chapter 01: Clinical Research at the NCI
- Chapter 02: Attracted to the Division of Surgery at MD Anderson
- Chapter 03: A Vision for the Department of Thoracic and Cardiovascular Surgery (late Eighties): Building Research, an Oncology Perspective and Multi-disciplinary Collaboration, and Training Programs
- Chapter 04: Research into Gene Therapies and Immunotherapies, and Thoughts on the Research Culture of the Division
- Chapter 05: Evaluating the Division System (1985 – 1995)
Identifier
RothJ_01_20190314
Publication Date
3-14-2019
Publisher
Historical Resources Center
City
Houston, Texas
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Disciplines
History of Science, Technology, and Medicine | Oncology | Oral History | Surgery
Recommended Citation
Roth, Jack MD; Balch, Charles M. MD; and Rosolowski, Tacey A. PhD, "Jack Roth, MD, Oral History Interview, The First 50 Years of Surgery at MD Anderson (1945 – 1995), March 14, 2019" (2019). History of Surgery - Interview Sessions. 1.
https://openworks.mdanderson.org/surgeryhist_interviewsessions/1
Conditions Governing Access
Open
About the Interview
Name: Jack Roth, MD
Interviewed: 2019, Division of Surgery Project
Primary appt: Department of Thoracic and Cardiovascular Surgery
Research: Neoadjuvant chemotherapy --squamous carcinoma of esophagus and open lung biopsy in immunocompromised patients; first gene therapy trials for lung cancer; multidisciplinary protocols in thoracic oncology; first randomized trial --survival benefit with neoadjuvant chemotherapy in stage IIIA resectable lung cancer.
Admin: Chair, Department of Thoracic and Cardiovascular Surgery Chief (1986-2007); Section of Thoracic Molecular Oncology, Department of Thoracic and Cardiovascular Surgery (1995-present); Deputy Head for Research, Division of Surgery (1987−1993); founding director, W. M. Keck Center for Innovative Cancer Therapies
About the Interview Subject
Dr. Jack Roth came to MD Anderson in 1986 from the National Cancer Institute’s Surgery Branch to serve as professor and chair of the Department of Thoracic and Cardiovascular Surgery. He serves as founding director of the W. M. Keck Center for Innovative Cancer Therapies and holds academic appointments in UTMDACC’s Department of Molecular and Cellular Oncology and the Department of Cardiothoracic and Vascular Surgery at The University of Texas Medical School at Houston.